A Phase II Trial of Irinotecan and Cisplatin in Patients with Metastatic Neuroendocrine Tumors
2006; Springer Science+Business Media; Volume: 51; Issue: 6 Linguagem: Inglês
10.1007/s10620-006-8001-3
ISSN1573-2568
AutoresMatthew H. Kulke, Bingyan Wu, David P. Ryan, Peter C. Enzinger, Andrew X. Zhu, Jeffrey W. Clark, Craig C. Earle, Ann Michelini, Charles S. Fuchs,
Tópico(s)Neuroblastoma Research and Treatments
Referência(s)